Loading...
OTCM
BTCY
Market cap11mUSD
Jun 13, Last price  
0.52USD
1D
-6.20%
1Q
-6.42%
Jan 2017
-96.97%
IPO
-97.05%
Name

Biotricity Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
1.07
EPS
Div Yield, %
Shrs. gr., 5y
10.08%
Rev. gr., 5y
97.82%
Revenues
12m
+25.15%
00000398,2001,417,7253,384,7677,650,2699,639,05712,063,345
Net income
-14m
L-24.46%
-91,072-90,813-5,185,852-7,809,291-8,623,738-8,592,065-11,066,942-15,491,176-29,130,477-18,658,143-14,094,283
CFO
-7m
L-50.59%
-8,222-26,951-1,963,975-3,748,865-4,874,535-5,220,847-7,862,779-11,080,831-15,163,384-13,547,935-6,693,912
Earnings
Jun 25, 2025

Profile

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
IPO date
Oct 26, 2015
Employees
55
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032015‑122015‑08
Income
Revenues
12,063
25.15%
9,639
26.00%
Cost of revenue
20,892
25,049
Unusual Expense (Income)
NOPBT
(8,828)
(15,410)
NOPBT Margin
Operating Taxes
2,401
Tax Rate
NOPAT
(8,828)
(17,810)
Net income
(14,094)
-24.46%
(18,658)
-35.95%
Dividends
(18)
(947)
Dividend yield
0.14%
23.51%
Proceeds from repurchase of equity
119
(883)
BB yield
-0.90%
21.93%
Debt
Debt current
12,094
5,110
Long-term debt
13,171
16,158
Deferred revenue
Other long-term liabilities
1,436
759
Net debt
24,329
20,601
Cash flow
Cash from operating activities
(6,694)
(13,548)
CAPEX
Cash from investing activities
Cash from financing activities
6,742
2,002
FCF
(5,260)
(14,666)
Balance
Cash
786
570
Long term investments
150
96
Excess cash
333
185
Stockholders' equity
(125,969)
(112,671)
Invested Capital
121,307
111,524
ROIC
ROCE
189.35%
1,342.89%
EV
Common stock shares outstanding
8,992
8,660
Price
1.48
218.28%
0.47
-79.52%
Market cap
13,308
230.49%
4,027
-76.58%
EV
39,126
24,628
EBITDA
(6,655)
(15,404)
EV/EBITDA
Interest
5,192
2,583
Interest/NOPBT